|  | PFS a | OS a |  | Chemotherapy response b | |||
---|---|---|---|---|---|---|---|---|
Variables | Case No. (%) | HR (95% CI) | P Value | HR (95% CI) | P Value | Case No. (%) | OR (95% CI) | P Value |
FIGO stage | ||||||||
I–II | 18 (29.0) | 0.552 (0.184–1.658) | 0.290 | 0.204 (0.027–1.551) | 0.125 | 16 (29.0) | - | - |
III–IV | 44 (71.0) | 1 |  | 1 |  | 42 (71.0) |  |  |
Let-7e expression | Â | Â | Â | Â | Â | Â | Â | Â |
Low | 23 (37.1) | 2.037 (0.912–4.554) | 0.083 | 3.235 (1.258–8.317) | 0.015 | 21 (37.1) | 19.696 (3.477–111.572) | 0.001 |
High | 39 (62.9) | 1 | Â | 1 | Â | 37 (62.9) | 1 | Â |
BRCA1 expression | Â | Â | Â | Â | Â | Â | Â | Â |
Low | 25 (40.3) | - | - | - | - | 23 (40.3) | 1 | 0.155 |
High | 37 (59.7) |  |  |  |  | 35 (59.7) | 5.042 (0.541–47.011) |  |
Rad51 expression | Â | Â | Â | Â | Â | Â | Â | Â |
Low | 32 (51.6) | 1 | 0.029 | 1 | 0.404 | 30 (51.6) | 1 | 0.163 |
High | 30 (48.4) | 2.519 (1.098–5.779) |  | 1.500 (0.579–3.891) |  | 28 (48.4) | 4.290 (0.553–33.26) |  |